{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:18:35Z","timestamp":1782285515288,"version":"3.54.5"},"reference-count":74,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Open Project of Beijing Key Laboratory of Low Oxygen Preconditioning Translational Medicine","award":["NDK-2025-06"],"award-info":[{"award-number":["NDK-2025-06"]}]},{"DOI":"10.13039\/501100005089","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7192017"],"award-info":[{"award-number":["7192017"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parkinson\u2019s disease (PD) is a common neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta and the abnormal aggregation of \u03b1-synuclein (\u03b1-Syn) into Lewy bodies. While these pathological features arise from genetic susceptibility, environmental exposures, and age-related cellular deteriorations, the precise interactions among these factors remain incompletely understood. Mounting evidence implicates that copper ions are playing a critical role in PD pathogenesis, particularly in regulating dopaminergic neuron survival and the aggregation dynamics of \u03b1-Syn.<\/jats:p>","DOI":"10.1515\/revneuro-2025-0134","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T05:53:57Z","timestamp":1772517237000},"page":"409-421","source":"Crossref","is-referenced-by-count":2,"title":["Orchestrating pathogenesis: copper ions as the conductor of molecular dysfunction in Parkinson\u2019s disease and therapeutic avenues"],"prefix":"10.1515","volume":"37","author":[{"given":"Zhe","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Neurobiology , 12517 Capital Medical University , Beijing 100069 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanning","family":"Cai","sequence":"additional","affiliation":[{"name":"Key Laboratory for Neurodegenerative Disease of the Ministry of Education , Beijing 100069 , China"},{"name":"Department of Biobank , 12517 Xuanwu Hospital of Capital Medical University , Beijing 100069 , China"},{"name":"National Clinical Research Center for Geriatric Disorders , Beijing 100053 , China"},{"name":"Beijing Geriatric Medical Research Center , Beijing 100053 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Neurobiology , 12517 Capital Medical University , Beijing 100069 , China"},{"name":"Key Laboratory for Neurodegenerative Disease of the Ministry of Education , Beijing 100069 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"2026060414455193160_j_revneuro-2025-0134_ref_001","doi-asserted-by":"crossref","unstructured":"Aaseth, J.O. and Nurchi, V.M. (2022). Chelation combination\u00a0\u2013\u00a0a strategy to mitigate the neurotoxicity of manganese, iron, and copper? Biomolecules 12: 1713, https:\/\/doi.org\/10.3390\/biom12111713.","DOI":"10.3390\/biom12111713"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_002","doi-asserted-by":"crossref","unstructured":"Ahmadi, M., Eftekhari Kenzerki, M., Akrami, S.M., Pashangzadeh, S., Hajiesmaeili, F., Rahnavard, S., Habibipour, L., Saffarzadeh, N., and Mousavi, P. (2021). Overexpression of HPRT1 is associated with poor prognosis in head and neck squamous cell carcinoma. FEBS Open Bio. 11: 2525\u20132540, https:\/\/doi.org\/10.1002\/2211-5463.13250.","DOI":"10.1002\/2211-5463.13250"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_003","doi-asserted-by":"crossref","unstructured":"Batzios, S., Tal, G., DiStasio, A.T., Peng, Y., Charalambous, C., Nicolaides, P., Kamsteeg, E.J., Korman, S.H., Mandel, H., Steinbach, P.J., et al.. (2022). Newly identified disorder of copper metabolism caused by variants in CTR1, a high-affinity copper transporter. Hum. Mol. Genet. 31: 4121\u20134130, https:\/\/doi.org\/10.1093\/hmg\/ddac156.","DOI":"10.1093\/hmg\/ddac156"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_004","doi-asserted-by":"crossref","unstructured":"Bisaglia, M., Filograna, R., Beltramini, M., and Bubacco, L. (2014). Are dopamine derivatives implicated in the pathogenesis of Parkinson\u2019s disease? Ageing Res. Rev. 13: 107\u2013114, https:\/\/doi.org\/10.1016\/j.arr.2013.12.009.","DOI":"10.1016\/j.arr.2013.12.009"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_005","doi-asserted-by":"crossref","unstructured":"Blauwendraat, C., Nalls, M.A., and Singleton, A.B. (2020). The genetic architecture of Parkinson\u2019s disease. Lancet Neurol. 19: 170\u2013178, https:\/\/doi.org\/10.1016\/s1474-4422(19)30287-x.","DOI":"10.1016\/S1474-4422(19)30287-X"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_006","doi-asserted-by":"crossref","unstructured":"Bortolus, M., Bisaglia, M., Zoleo, A., Fittipaldi, M., Benfatto, M., Bubacco, L., and Maniero, A.L. (2010). Structural characterization of a high affinity mononuclear site in the copper(II)-\u03b1-synuclein complex. J.\u00a0Am. Chem. Soc. 132: 18057\u201318066, https:\/\/doi.org\/10.1021\/ja103338n.","DOI":"10.1021\/ja103338n"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_007","doi-asserted-by":"crossref","unstructured":"Boyd, S.D., Ullrich, M.S., Skopp, A., and Winkler, D.D. (2020). Copper sources for Sod1 activation. Antioxidants (Basel) 9: 500, https:\/\/doi.org\/10.3390\/antiox9060500.","DOI":"10.3390\/antiox9060500"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_008","doi-asserted-by":"crossref","unstructured":"Br\u00fccke, T. and Br\u00fccke, C. (2022). Dopamine transporter (DAT) imaging in Parkinson\u2019s disease and related disorders. J.\u00a0Neural Transm. (Vienna) 129: 581\u2013594.","DOI":"10.1007\/s00702-021-02452-7"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_009","doi-asserted-by":"crossref","unstructured":"Carmona, A., Carboni, E., Gomes, L.C., Roudeau, S., Maass, F., Lenz, C., Ortega, R., and Lingor, P. (2024). Metal dyshomeostasis in the substantia nigra of patients with Parkinson\u2019s disease or multiple sclerosis. J.\u00a0Neurochem. 168: 128\u2013141, https:\/\/doi.org\/10.1111\/jnc.16040.","DOI":"10.1111\/jnc.16040"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_010","doi-asserted-by":"crossref","unstructured":"Chinta, S.J., Rajagopalan, S., Butterfield, D.A., and Andersen, J.K. (2006). In vitro and in\u00a0vivo neuroprotection by gamma-glutamylcysteine ethyl ester against MPTP: relevance to the role of glutathione in Parkinson\u2019s disease. Neurosci. Lett. 402: 137\u2013141, https:\/\/doi.org\/10.1016\/j.neulet.2006.03.056.","DOI":"10.1016\/j.neulet.2006.03.056"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_011","doi-asserted-by":"crossref","unstructured":"Choi, T.S., Lee, J., Han, J.Y., Jung, B.C., Wongkongkathep, P., Loo, J.A., Lee, M.J., and Kim, H.I. (2018). Supramolecular modulation of structural polymorphism in pathogenic \u03b1-synuclein fibrils using copper(II) coordination. Angew Chem. Int. Ed. Engl. 57: 3099\u20133103, https:\/\/doi.org\/10.1002\/anie.201712286.","DOI":"10.1002\/anie.201712286"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_012","doi-asserted-by":"crossref","unstructured":"Cubells, J.F. and Zabetian, C.P. (2004). Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology. Psychopharmacology (Berl) 174: 463\u2013476, https:\/\/doi.org\/10.1007\/s00213-004-1840-8.","DOI":"10.1007\/s00213-004-1840-8"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_013","doi-asserted-by":"crossref","unstructured":"Cukierman, D.S., L\u00e1zaro, D.F., Sacco, P., Ferreira, P.R., Diniz, R., Fern\u00e1ndez, C.O., Outeiro, T.F., and Rey, N.A. (2020). X1INH, an improved next-generation affinity-optimized hydrazonic ligand, attenuates abnormal copper(I)\/copper(II)-\u03b1-Syn interactions and affects protein aggregation in a cellular model of synucleinopathy. Dalton Trans. 49: 16252\u201316267, https:\/\/doi.org\/10.1039\/d0dt01138j.","DOI":"10.1039\/D0DT01138J"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_014","doi-asserted-by":"crossref","unstructured":"Dexter, D.T., Wells, F.R., Lees, A.J., Agid, F., Agid, Y., Jenner, P., and Marsden, C.D. (1989). Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson\u2019s disease. J.\u00a0Neurochem. 52: 1830\u20131836, https:\/\/doi.org\/10.1111\/j.1471-4159.1989.tb07264.x.","DOI":"10.1111\/j.1471-4159.1989.tb07264.x"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_015","doi-asserted-by":"crossref","unstructured":"Dorsey, E.R., Constantinescu, R., Thompson, J.P., Biglan, K.M., Holloway, R.G., Kieburtz, K., Marshall, F.J., Ravina, B.M., Schifitto, G., Siderowf, A., et al.. (2007). Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68: 384\u2013386, https:\/\/doi.org\/10.1212\/01.wnl.0000247740.47667.03.","DOI":"10.1212\/01.wnl.0000247740.47667.03"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_016","doi-asserted-by":"crossref","unstructured":"Duvall, B., Zimmermann, S.C., Gao, R.D., Thomas, A.G., Kal\u010dic, F., Veeravalli, V., Elgogary, A., Rais, R., Rojas, C., Le, A., et al.. (2020). Allosteric kidney-type glutaminase (GLS) inhibitors with a mercaptoethyl linker. Bioorg. Med. Chem. 28: 115698, https:\/\/doi.org\/10.1016\/j.bmc.2020.115698.","DOI":"10.1016\/j.bmc.2020.115698"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_017","doi-asserted-by":"crossref","unstructured":"Dwivedi, M., Jose, S., Gupta, M., Devi, S.S., Raj, R., and Kumar, D. (2024). Copper transporter protein (MctB) as a therapeutic target to elicit antimycobacterial activity against tuberculosis. J.\u00a0Biomol. Struct. Dyn. 42: 5334\u20135348, https:\/\/doi.org\/10.1080\/07391102.2023.2226728.","DOI":"10.1080\/07391102.2023.2226728"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_018","doi-asserted-by":"crossref","unstructured":"Eum, W.S., Shin, M.J., Lee, C.H., Yeo, H.J., Yeo, E.J., Choi, Y.J., Kwon, H.J., Kim, D.S., Kwon, O.S., Lee, K.W., et al.. (2019). Neuroprotective effects of Tat-ATOX1 protein against MPP(+)-induced SH-SY5Y cell deaths and in MPTP-induced mouse model of Parkinson\u2019s disease. Biochimie 156: 158\u2013168, https:\/\/doi.org\/10.1016\/j.biochi.2018.10.010.","DOI":"10.1016\/j.biochi.2018.10.010"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_019","doi-asserted-by":"crossref","unstructured":"Fu, S., Jiang, W., and Zheng, W. (2015). Age-dependent increase of brain copper levels and expressions of copper regulatory proteins in the subventricular zone and choroid plexus. Front. Mol. Neurosci. 8: 22, https:\/\/doi.org\/10.3389\/fnmol.2015.00022.","DOI":"10.3389\/fnmol.2015.00022"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_020","doi-asserted-by":"crossref","unstructured":"Fujisawa, C., Kodama, H., Sato, Y., Mimaki, M., Yagi, M., Awano, H., Matsuo, M., Shintaku, H., Yoshida, S., Takayanagi, M., et al.. (2022). Early clinical signs and treatment of Menkes disease. Mol. Genet. Metab. Rep 31: 100849, https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100849.","DOI":"10.1016\/j.ymgmr.2022.100849"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_021","doi-asserted-by":"crossref","unstructured":"Gan, R.Y., Li, H.B., Sui, Z.Q., and Corke, H. (2018). Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): an updated review. Crit. Rev. Food Sci. Nutr. 58: 924\u2013941, https:\/\/doi.org\/10.1080\/10408398.2016.1231168.","DOI":"10.1080\/10408398.2016.1231168"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_022","doi-asserted-by":"crossref","unstructured":"Gromadzka, G., Tarnacka, B., Flaga, A., and Adamczyk, A. (2020). Copper dyshomeostasis in neurodegenerative diseases-therapeutic implications. Int. J.\u00a0Mol. Sci. 21: 9259, https:\/\/doi.org\/10.3390\/ijms21239259.","DOI":"10.3390\/ijms21239259"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_023","doi-asserted-by":"crossref","unstructured":"Hartwig, C., M\u00e9ndez, G.M., Bhattacharjee, S., Vrailas-Mortimer, A.D., Zlatic, S.A., Freeman, A.A.H., Gokhale, A., Concilli, M., Werner, E., Sapp Savas, C., et al.. (2021). Golgi-dependent copper homeostasis sustains synaptic development and mitochondrial content. J.\u00a0Neurosci. 41: 215\u2013233, https:\/\/doi.org\/10.1523\/jneurosci.1284-20.2020.","DOI":"10.1523\/JNEUROSCI.1284-20.2020"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_024","doi-asserted-by":"crossref","unstructured":"Henr\u00edquez, G., Gomez, A., Guerrero, E., and Narayan, M. (2020). Potential role of natural polyphenols against protein aggregation toxicity: in\u00a0vitro, in\u00a0vivo, and clinical studies. ACS Chem. Neurosci. 11: 2915\u20132934.","DOI":"10.1021\/acschemneuro.0c00381"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_025","doi-asserted-by":"crossref","unstructured":"Huang, M., Zhang, Y., and Liu, X. (2024). The mechanism of cuproptosis in Parkinson\u2019s disease. Ageing Res. Rev. 95: 102214, https:\/\/doi.org\/10.1016\/j.arr.2024.102214.","DOI":"10.1016\/j.arr.2024.102214"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_026","doi-asserted-by":"crossref","unstructured":"Hussain, F., Rodriguez-Granillo, A., and Wittung-Stafshede, P. (2009). Lysine-60 in copper chaperone Atox1 plays an essential role in Adduct formation with a target Wilson disease domain. J.\u00a0Am. Chem. Soc. 131: 16371\u201316373, https:\/\/doi.org\/10.1021\/ja9058266.","DOI":"10.1021\/ja9058266"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_027","doi-asserted-by":"crossref","unstructured":"Jin, T., Zhang, Y., Botchway, B.O.A., Zhang, J., Fan, R., Zhang, Y., and Liu, X. (2022). Curcumin can improve Parkinson\u2019s disease via activating BDNF\/PI3k\/Akt signaling pathways. Food Chem. Toxicol. 164: 113091, https:\/\/doi.org\/10.1016\/j.fct.2022.113091.","DOI":"10.1016\/j.fct.2022.113091"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_028","doi-asserted-by":"crossref","unstructured":"Jomova, K., Lawson, M., Drostinova, L., Lauro, P., Poprac, P., Brezova, V., Michalik, M., Lukes, V., and Valko, M. (2017). Protective role of quercetin against copper(II)-induced oxidative stress: a spectroscopic, theoretical and DNA damage study. Food Chem. Toxicol. 110: 340\u2013350, https:\/\/doi.org\/10.1016\/j.fct.2017.10.042.","DOI":"10.1016\/j.fct.2017.10.042"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_029","doi-asserted-by":"crossref","unstructured":"Jomova, K., Makova, M., Alomar, S.Y., Alwasel, S.H., Nepovimova, E., Kuca, K., Rhodes, C.J., and Valko, M. (2022). Essential metals in health and disease. Chem. Biol. Interact. 367: 110173, https:\/\/doi.org\/10.1016\/j.cbi.2022.110173.","DOI":"10.1016\/j.cbi.2022.110173"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_030","doi-asserted-by":"crossref","unstructured":"Karpenko, M.N., Muruzheva, Z.M., Ilyechova, E.Y., Babich, P.S., and Puchkova, L.V. (2023). Abnormalities in copper status associated with an elevated risk of Parkinson\u2019s phenotype development. Antioxidants (Basel) 12: 1654, https:\/\/doi.org\/10.3390\/antiox12091654.","DOI":"10.3390\/antiox12091654"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_031","doi-asserted-by":"crossref","unstructured":"Kempuraj, D., Thangavel, R., Kempuraj, D.D., Ahmed, M.E., Selvakumar, G.P., Raikwar, S.P., Zaheer, S.A., Iyer, S.S., Govindarajan, R., Chandrasekaran, P.N., et al.. (2021). Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma. Biofactors 47: 190\u2013197, https:\/\/doi.org\/10.1002\/biof.1687.","DOI":"10.1002\/biof.1687"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_032","doi-asserted-by":"crossref","unstructured":"Kim, B., Brueggemeyer, M.T., Transue, W.J., Park, Y., Cho, J., Siegler, M.A., Solomon, E.I., and Karlin, K.D. (2023). Fenton-like chemistry by a copper(I) complex and H(2)O(2) relevant to enzyme peroxygenase C-H hydroxylation. J.\u00a0Am. Chem. Soc. 145: 11735\u201311744, https:\/\/doi.org\/10.1021\/jacs.3c02273.","DOI":"10.1021\/jacs.3c02273"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_033","doi-asserted-by":"crossref","unstructured":"Koh, S.H., Lee, S.M., Kim, H.Y., Lee, K.Y., Lee, Y.J., Kim, H.T., Kim, J., Kim, M.H., Hwang, M.S., Song, C., et al.. (2006). The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice. Neurosci. Lett. 395: 103\u2013107, https:\/\/doi.org\/10.1016\/j.neulet.2005.10.056.","DOI":"10.1016\/j.neulet.2005.10.056"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_034","doi-asserted-by":"crossref","unstructured":"Kumar, S., Gupta, S.K., and Pahwa, R. (2023). Designing lisuride intranasal nanocarrier system for reduction of oxidative damage with enhanced dopamine level in brain for Parkinsonism. J.\u00a0Psychiatr. Res. 165: 205\u2013218, https:\/\/doi.org\/10.1016\/j.jpsychires.2023.07.030.","DOI":"10.1016\/j.jpsychires.2023.07.030"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_035","doi-asserted-by":"crossref","unstructured":"Lanoue, V., Chai, Y.J., Brouillet, J.Z., Weckhuysen, S., Palmer, E.E., Collins, B.M., and Meunier, F.A. (2019). STXBP1 encephalopathy: connecting neurodevelopmental disorders with \u03b1-synucleinopathies? Neurology 93: 114\u2013123, https:\/\/doi.org\/10.1212\/wnl.0000000000007786.","DOI":"10.1212\/WNL.0000000000007786"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_036","doi-asserted-by":"crossref","unstructured":"Lanza, V., Milardi, D., Di Natale, G., and Pappalardo, G. (2018). Repurposing of copper(II)-chelating drugs for the treatment of neurodegenerative diseases. Curr. Med. Chem. 25: 525\u2013539, https:\/\/doi.org\/10.2174\/0929867324666170518094404.","DOI":"10.2174\/0929867324666170518094404"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_037","doi-asserted-by":"crossref","unstructured":"Li, Y., Yang, C., Wang, S., Yang, D., Zhang, Y., Xu, L., Ma, L., Zheng, J., Petersen, R.B., Zheng, L., et al.. (2020). Copper and iron ions accelerate the prion-like propagation of \u03b1-synuclein: a vicious cycle in Parkinson\u2019s disease. Int. J.\u00a0Biol. Macromol. 163: 562\u2013573, https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.06.274.","DOI":"10.1016\/j.ijbiomac.2020.06.274"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_038","doi-asserted-by":"crossref","unstructured":"Li, B., Yang, R., Chen, X., He, J., Lu, Z., and Li, Y. (2025). Copper mitigates atrazine-induced neurotoxicity in Parkinson\u2019s disease models. Mol. Neurobiol. 62: 5202\u20135215, https:\/\/doi.org\/10.1007\/s12035-024-04609-3.","DOI":"10.1007\/s12035-024-04609-3"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_039","doi-asserted-by":"crossref","unstructured":"Lin, C.H., Wei, P.C., Chen, C.M., Huang, Y.T., Lin, J.L., Lo, Y.S., Lin, J.L., Lin, C.Y., Wu, Y.R., Chang, K.H., et al.. (2020). Lactulose and melibiose attenuate MPTP-induced Parkinson\u2019s disease in mice by inhibition of oxidative stress, reduction of neuroinflammation and up-regulation of autophagy. Front. Aging Neurosci. 12: 226, https:\/\/doi.org\/10.3389\/fnagi.2020.00226.","DOI":"10.3389\/fnagi.2020.00226"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_040","doi-asserted-by":"crossref","unstructured":"Lin, J., Zhang, G., Lou, B., Sun, Y., Jia, X., Wang, M., Zhou, J., and Xia, Z. (2024). Identification of copper metabolism-related markers in Parkinson\u2019s disease. Ann. Med. 56: 2425064, https:\/\/doi.org\/10.1080\/07853890.2024.2425064.","DOI":"10.1080\/07853890.2024.2425064"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_041","doi-asserted-by":"crossref","unstructured":"Lin, W., Huang, C., Tan, Z., Xu, H., Wei, W., and Wang, L. (2025). Cu(II)-bis(thioureido) complex: a potential radiotracer for detecting oxidative stress and neuroinflammation in neurodegenerative diseases. Semin. Nucl. Med. 55: 577\u2013586, https:\/\/doi.org\/10.1053\/j.semnuclmed.2025.03.008.","DOI":"10.1053\/j.semnuclmed.2025.03.008"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_042","doi-asserted-by":"crossref","unstructured":"Liu, H. and Tang, T. (2022). Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set. Front. Oncol. 12: 952290, https:\/\/doi.org\/10.3389\/fonc.2022.952290.","DOI":"10.3389\/fonc.2022.952290"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_043","doi-asserted-by":"crossref","unstructured":"Liu, H., Deng, H., Jian, Z., Cui, H., Guo, H., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X., et al.. (2021). Copper exposure induces hepatic G0\/G1\u00a0cell-cycle arrest through suppressing the Ras\/PI3K\/Akt signaling pathway in mice. Ecotoxicol. Environ. Saf. 222: 112518, https:\/\/doi.org\/10.1016\/j.ecoenv.2021.112518.","DOI":"10.1016\/j.ecoenv.2021.112518"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_044","doi-asserted-by":"crossref","unstructured":"Mamashli, F., Meratan, A.A., Ghasemi, A., Obeidi, N., Salmani, B., Atarod, D., Pirhaghi, M., Moosavi-Movahedi, F., Mohammad-Zaheri, M., Shahsavani, M.B., et al.. (2023). Neuroprotective effect of propolis polyphenol-based nanosheets in cellular and animal models of rotenone-induced Parkinson\u2019s disease. ACS Chem. Neurosci. 14: 851\u2013863, https:\/\/doi.org\/10.1021\/acschemneuro.2c00605.","DOI":"10.1021\/acschemneuro.2c00605"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_045","doi-asserted-by":"crossref","unstructured":"Meek, S., Thomson, A.J., Sutherland, L., Sharp, M.G., Thomson, J., Bishop, V., Meddle, S.L., Gloaguen, Y., Weidt, S., Singh-Dolt, K., et al.. (2022). Reduced levels of dopamine and altered metabolism in brains of HPRT knock-out rats: a new rodent model of Lesch-Nyhan disease. Sci. Rep. 6: 25592, https:\/\/doi.org\/10.1038\/srep25592.","DOI":"10.1038\/srep25592"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_046","doi-asserted-by":"crossref","unstructured":"Monzani, E., Nicolis, S., Dell\u2019Acqua, S., Capucciati, A., Bacchella, C., Zucca, F.A., Mosharov, E.V., Sulzer, D., Zecca, L., and Casella, L. (2019). Dopamine, oxidative stress and protein-quinone modifications in Parkinson\u2019s and other neurodegenerative diseases. Angew Chem. Int. Ed. Engl. 58: 6512\u20136527, https:\/\/doi.org\/10.1002\/anie.201811122.","DOI":"10.1002\/anie.201811122"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_047","doi-asserted-by":"crossref","unstructured":"Mosharov, E.V., Borgkvist, A., and Sulzer, D. (2015). Presynaptic effects of levodopa and their possible role in dyskinesia. Mov. Disord. 30: 45\u201353, https:\/\/doi.org\/10.1002\/mds.26103.","DOI":"10.1002\/mds.26103"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_048","doi-asserted-by":"crossref","unstructured":"Moussa, C., Hebron, M., Huang, X., Ahn, J., Rissman, R.A., Aisen, P.S., and Turner, R.S. (2017). Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer\u2019s disease. J.\u00a0Neuroinflammation 14: 1, https:\/\/doi.org\/10.1186\/s12974-016-0779-0.","DOI":"10.1186\/s12974-016-0779-0"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_049","doi-asserted-by":"crossref","unstructured":"Nabi, A.G., Aman Ur, R., Hussain, A., Chass, G.A., and Di Tommaso, D. (2022). Optimal icosahedral copper-based bimetallic clusters for the selective electrocatalytic CO(2) conversion to one carbon products. Nanomaterials (Basel) 13: 87, https:\/\/doi.org\/10.3390\/nano13010087.","DOI":"10.3390\/nano13010087"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_050","doi-asserted-by":"crossref","unstructured":"Naletova, I., Satriano, C., Pietropaolo, A., Gian\u00ec, F., Pandini, G., Triaca, V., Amadoro, G., Latina, V., Calissano, P., Travaglia, A., et al.. (2019). The copper(II)-assisted connection between NGF and BDNF by means of nerve growth factor-mimicking short peptides. Cells 8: 301, https:\/\/doi.org\/10.3390\/cells8040301.","DOI":"10.3390\/cells8040301"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_051","doi-asserted-by":"crossref","unstructured":"Okita, Y., Rcom-H\u2019cheo-Gauthier, A.N., Goulding, M., Chung, R.S., Faller, P., and Pountney, D.L. (2017). Metallothionein, copper and alpha-synuclein in alpha-synucleinopathies. Front. Neurosci. 11: 114.","DOI":"10.3389\/fnins.2017.00114"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_052","doi-asserted-by":"crossref","unstructured":"Pham, A.N. and Waite, T.D. (2014). Cu(II)-catalyzed oxidation of dopamine in aqueous solutions: mechanism and kinetics. J.\u00a0Inorg. Biochem. 137: 74\u201384, https:\/\/doi.org\/10.1016\/j.jinorgbio.2014.03.018.","DOI":"10.1016\/j.jinorgbio.2014.03.018"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_053","doi-asserted-by":"crossref","unstructured":"Poursani, E.M., Mercatelli, D., Raninga, P., Bell, J.L., Saletta, F., Kohane, F.V., Neumann, D.P., Zheng, Y., Rouaen, J.R.C., Jue, T.R., et al.. (2023). Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-\u03b2 signaling pathways in cancer. Cell Biosci. 13: 132, https:\/\/doi.org\/10.1186\/s13578-023-01083-7.","DOI":"10.1186\/s13578-023-01083-7"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_054","doi-asserted-by":"crossref","unstructured":"Roudeau, S., Trist, B.G., Carmona, A., Davies, K.M., Halliday, G.M., Rufin, Y., Claverol, S., Van Malderen, S.J.M., Falkenberg, G., Double, K.L., et al.. (2021). Native separation and metallation analysis of SOD1 protein from the human central nervous system: a methodological workflow. Anal. Chem. 93: 11108\u201311115, https:\/\/doi.org\/10.1021\/acs.analchem.1c01128.","DOI":"10.1021\/acs.analchem.1c01128"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_055","doi-asserted-by":"crossref","unstructured":"Rowlands, B.D., Trist, B.G., Karozis, C., Schaffer, G., Mor, D., Harwood, R., Rosolen, S.A., Cottam, V., Persson-Carboni, F., Richardson, M., et al.. (2025). Copper supplementation mitigates Parkinson-like wild-type SOD1 pathology and nigrostriatal degeneration in a novel mouse model. Acta Neuropathol. Commun. 13: 133, https:\/\/doi.org\/10.1186\/s40478-025-02048-2.","DOI":"10.1186\/s40478-025-02048-2"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_056","doi-asserted-by":"crossref","unstructured":"Rutledge, J., Lehallier, B., Zarifkar, P., Losada, P.M., Shahid-Besanti, M., Western, D., Gorijala, P., Ryman, S., Yutsis, M., Deutsch, G.K., et al. (2024). Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson\u2019s disease. Acta Neuropathol. 147: 52, https:\/\/doi.org\/10.1007\/s00401-024-02706-0.","DOI":"10.1007\/s00401-024-02706-0"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_057","doi-asserted-by":"crossref","unstructured":"Shen, C., Sheng, Z.G., Shao, J., Tang, M., Mao, L., Huang, C.H., Zhang, Z.H., and Zhu, B.Z. (2023). Mechanistic investigation of the differential synergistic neurotoxicity between pesticide metam sodium and copper or zinc. Chemosphere 328: 138430, https:\/\/doi.org\/10.1016\/j.chemosphere.2023.138430.","DOI":"10.1016\/j.chemosphere.2023.138430"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_058","doi-asserted-by":"crossref","unstructured":"Sian, J., Dexter, D.T., Lees, A.J., Daniel, S., Agid, Y., Javoy-Agid, F., Jenner, P., and Marsden, C.D. (1994). Alterations in glutathione levels in Parkinson\u2019s disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36: 348\u2013355, https:\/\/doi.org\/10.1002\/ana.410360305.","DOI":"10.1002\/ana.410360305"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_059","doi-asserted-by":"crossref","unstructured":"Sidorova, Y. and Domanskyi, A. (2020). Detecting oxidative stress biomarkers in neurodegenerative disease models and patients. Methods Protoc. 3: 66, https:\/\/doi.org\/10.3390\/mps3040066.","DOI":"10.3390\/mps3040066"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_060","doi-asserted-by":"crossref","unstructured":"Teng, Y., Zhao, J., Ding, L., Ding, Y., and Zhou, P. (2019). Complex of EGCG with Cu(II) suppresses amyloid aggregation and Cu(II)-induced cytotoxicity of \u03b1-synuclein. Molecules 24: 2940, https:\/\/doi.org\/10.3390\/molecules24162940.","DOI":"10.3390\/molecules24162940"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_061","doi-asserted-by":"crossref","unstructured":"Tsang, T., Davis, C.I., and Brady, D.C. (2021). Copper biology. Curr. Biol. 31: R421\u2013R427, https:\/\/doi.org\/10.1016\/j.cub.2021.03.054.","DOI":"10.1016\/j.cub.2021.03.054"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_062","doi-asserted-by":"crossref","unstructured":"Tsvetkov, P., Coy, S., Petrova, B., Dreishpoon, M., Verma, A., Abdusamad, M., Rossen, J., Joesch-Cohen, L., Humeidi, R., Spangler, R.D., et al.. (2022). Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375: 1254\u20131261, https:\/\/doi.org\/10.1126\/science.abf0529.","DOI":"10.1126\/science.abf0529"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_063","doi-asserted-by":"crossref","unstructured":"Valensin, D., Dell\u2019Acqua, S., Kozlowski, H., and Casella, L. (2016). Coordination and redox properties of copper interaction with \u03b1-synuclein. J.\u00a0Inorg. Biochem. 163: 292\u2013300, https:\/\/doi.org\/10.1016\/j.jinorgbio.2016.04.012.","DOI":"10.1016\/j.jinorgbio.2016.04.012"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_064","doi-asserted-by":"crossref","unstructured":"Walke, G., Kumar, R., and Wittung-Stafshede, P. (2024). Copper ion incorporation in \u03b1-synuclein amyloids. Protein Sci. 33: e4956, https:\/\/doi.org\/10.1002\/pro.4956.","DOI":"10.1002\/pro.4956"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_065","doi-asserted-by":"crossref","unstructured":"Wang, Y., Wang, X., Xie, R., Burger, J.C., Tong, Y., and Gong, S. (2023). Overcoming the blood-brain barrier for gene therapy via systemic administration of GSH-responsive silica nanocapsules. Adv. Mater. 35: e2208018, https:\/\/doi.org\/10.1002\/adma.202208018.","DOI":"10.1002\/adma.202208018"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_066","doi-asserted-by":"crossref","unstructured":"Xu, Y., Yang, J., Lu, Y., Qian, L.L., Yang, Z.Y., Han, R.M., Zhang, J.P., and Skibsted, L.H. (2020). Copper(II) coordination and translocation in luteolin and effect on radical scavenging. J.\u00a0Phys. Chem. B 124: 380\u2013388, https:\/\/doi.org\/10.1021\/acs.jpcb.9b10531.","DOI":"10.1021\/acs.jpcb.9b10531"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_067","doi-asserted-by":"crossref","unstructured":"Xue, Q., Kang, R., Klionsky, D.J., Tang, D., Liu, J., and Chen, X. (2023). Copper metabolism in cell death and autophagy. Autophagy 19: 2175\u20132195, https:\/\/doi.org\/10.1080\/15548627.2023.2200554.","DOI":"10.1080\/15548627.2023.2200554"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_068","doi-asserted-by":"crossref","unstructured":"Zeng, Z., Cen, Y., Xiong, L., Hong, G., Luo, Y., and Luo, X. (2024). Dietary copper intake and risk of Parkinson\u2019s disease: a cross-sectional study. Biol. Trace Elem. Res. 202: 955\u2013964, https:\/\/doi.org\/10.1007\/s12011-023-03750-9.","DOI":"10.1007\/s12011-023-03750-9"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_069","doi-asserted-by":"crossref","unstructured":"Zhao, X., Shao, Z., Zhang, Y., Liu, F., Liu, Z., and Liu, Z. (2018). Ceruloplasmin in Parkinson\u2019s disease and the nonmotor symptoms. Brain Behav. 8: e00995, https:\/\/doi.org\/10.1002\/brb3.995.","DOI":"10.1002\/brb3.995"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_070","doi-asserted-by":"crossref","unstructured":"Zhou, Q., Zhang, Y., Lu, L., Zhang, H., Zhao, C., Pu, Y., and Yin, L. (2022). Copper induces microglia-mediated neuroinflammation through ROS\/NF-\u03baB pathway and mitophagy disorder. Food Chem. Toxicol. 168: 113369, https:\/\/doi.org\/10.1016\/j.fct.2022.113369.","DOI":"10.1016\/j.fct.2022.113369"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_071","doi-asserted-by":"crossref","unstructured":"Zhou, H., Mao, Z., Zhang, X., Li, R., Yin, J., and Xu, Y. (2023). Neuroprotective effect of mangiferin against Parkinson\u2019s disease through G-protein-coupled receptor-interacting protein 1 (GIT1)-mediated antioxidant defense. ACS Chem. Neurosci. 14: 1379\u20131387, https:\/\/doi.org\/10.1021\/acschemneuro.2c00458.","DOI":"10.1021\/acschemneuro.2c00458"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_072","doi-asserted-by":"crossref","unstructured":"Zhu, M., Han, S., and Fink, A.L. (2013). Oxidized quercetin inhibits \u03b1-synuclein fibrillization. Biochim. Biophys. Acta 1830: 2872\u20132881, https:\/\/doi.org\/10.1016\/j.bbagen.2012.12.027.","DOI":"10.1016\/j.bbagen.2012.12.027"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_073","doi-asserted-by":"crossref","unstructured":"Zhu, M.J., Zhang, L., and Wang, C.P. (2024). Copper overload promotes \u03b2-amyloid induced NLRP3\/Caspase-1\/GSDMD-mediated pyroptosis in Alzheimer\u2019s disease. J.\u00a0Integr. Neurosci. 23: 194, https:\/\/doi.org\/10.31083\/j.jin2310194.","DOI":"10.31083\/j.jin2310194"},{"key":"2026060414455193160_j_revneuro-2025-0134_ref_074","doi-asserted-by":"crossref","unstructured":"Zucca, F.A., Basso, E., Cupaioli, F.A., Ferrari, E., Sulzer, D., Casella, L., and Zecca, L. (2014). Neuromelanin of the human substantia nigra: an update. Neurotox. Res. 25: 13\u201323, https:\/\/doi.org\/10.1007\/s12640-013-9435-y.","DOI":"10.1007\/s12640-013-9435-y"}],"container-title":["Reviews in the Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2025-0134\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2025-0134\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:55:32Z","timestamp":1780584932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2025-0134\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":74,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,6,4]]},"published-print":{"date-parts":[[2026,6,24]]}},"alternative-id":["10.1515\/revneuro-2025-0134"],"URL":"https:\/\/doi.org\/10.1515\/revneuro-2025-0134","relation":{},"ISSN":["0334-1763","2191-0200"],"issn-type":[{"value":"0334-1763","type":"print"},{"value":"2191-0200","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]}}}